We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-14.47%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.96B
AUM Growth
-$2.66B
Cap. Flow
-$2.46B
Cap. Flow %
-41.33%
Top 10 Hldgs %
19.41%
Holding
1,586
New
385
Increased
156
Reduced
122
Closed
320

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.3M
2
DELL icon
Dell
DELL
+$42.5M
3
JD icon
JD.com
JD
+$38.9M
4
TSM icon
TSMC
TSM
+$32.4M
5
ACC
American Campus Communities, Inc.
ACC
+$31.6M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Financials 9.38%
3 Healthcare 5.16%
4 Consumer Discretionary 4.89%
5 Communication Services 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CECO icon
1076
Ceco Environmental
CECO
$4.31B
$70K ﹤0.01%
+11,681
New +$64.7K
GTHX
1077
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$70K ﹤0.01%
+14,133
New +$78.3K
CAMP
1078
DELISTED
CalAmp Corp.
CAMP
$70K ﹤0.01%
+734
New +$102K
ALDX icon
1079
Aldeyra Therapeutics
ALDX
$95.3M
$69K ﹤0.01%
+17,311
New +$59.5K
INOD icon
1080
Innodata
INOD
$1.94B
$68K ﹤0.01%
+14,102
New +$91K
VMD icon
1081
Viemed Healthcare
VMD
$465M
$68K ﹤0.01%
+12,629
New +$68.1K
CVGI icon
1082
Commercial Vehicle Group
CVGI
$154M
$67K ﹤0.01%
+11,433
New +$77.8K
CLOER
1083
DELISTED
Clover Leaf Capital Corp. Rights
CLOER
$67K ﹤0.01%
620,000
LAXXR
1084
DELISTED
8i Acquisition 2 Corp Rights
LAXXR
$66K ﹤0.01%
+300,000
New +$86.3K
RYTM icon
1085
Rhythm Pharmaceuticals
RYTM
$7.28B
$65K ﹤0.01%
+15,713
New +$86K
VIGL
1086
DELISTED
Vigil Neuroscience
VIGL
$65K ﹤0.01%
25,337
-2,305
-8% -$9.1K
ARAY icon
1087
Accuray
ARAY
$26.8M
$64K ﹤0.01%
+32,811
New +$81.9K
LUNA
1088
DELISTED
Luna Innovations Incorporated
LUNA
$64K ﹤0.01%
+11,007
New +$64.9K
ALLR
1089
Allarity Therapeutics
ALLR
$19.6M
0
ORMP icon
1090
Oramed Pharmaceuticals
ORMP
$170M
$61K ﹤0.01%
+13,307
New +$71.1K
OTLY
1091
Oatly Group
OTLY
$447M
$61K ﹤0.01%
875
PANL icon
1092
Pangaea Logistics
PANL
$488M
$61K ﹤0.01%
12,084
+1,930
+19% +$10.6K
LVOXW
1093
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
$60K ﹤0.01%
+36,148
New +$9.89K
SPPI
1094
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$60K ﹤0.01%
+77,541
New +$68.3K
PSNL icon
1095
Personalis
PSNL
$1.28B
$59K ﹤0.01%
+17,127
New +$87.2K
CVM icon
1096
CEL-SCI Corp
CVM
$20.6M
$58K ﹤0.01%
+427
New +$44.5K
ITI
1097
DELISTED
Iteris, Inc.
ITI
$58K ﹤0.01%
+20,144
New +$56K
RCOR.WS
1098
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$57K ﹤0.01%
28,183
MBII
1099
DELISTED
Marrone Bio Innovations, Inc.
MBII
$56K ﹤0.01%
+48,156
New +$50.3K
CRMD icon
1100
CorMedix
CRMD
$596M
$54K ﹤0.01%
+13,517
New +$50.2K

Similar funds

LMR Partners's Q2 2022 Portfolio in Review

As of Q2 2022, LMR Partners held 1,586 positions worth $5.96B, down 31% from $8.61B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

LMR Partners withdrew a net $2.46B in Q2 2022, closing 320 positions and reducing 122 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Microsoft worth $42.8M.

  • LMR Partners's largest Q2 2022 buy was Microsoft: 166,753 shares worth $42.8M.
  • LMR Partners added most to TSMC in Q2 2022, an estimated $32.4M increase.
  • LMR Partners's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $553M.
  • LMR Partners fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $117M.
  • LMR Partners's ten largest holdings make up 19% of its $5.96B portfolio in Q2 2022.
  • LMR Partners opened 385 new positions and closed 320 in Q2 2022.
  • LMR Partners's portfolio value fell 31% quarter-over-quarter to $5.96B.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.